<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04030416</url>
  </required_header>
  <id_info>
    <org_study_id>BCA-21</org_study_id>
    <nct_id>NCT04030416</nct_id>
  </id_info>
  <brief_title>Comparing Medical Body Composition Analyzer Seca mBCA 555 With Seca mBCA 515</brief_title>
  <official_title>Clinical Accuracy Validation of the Medical Body Composition Analyzer Seca mBCA 555 in Comparison to Seca mBCA 515</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seca GmbH &amp; Co. Kg.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seca GmbH &amp; Co. Kg.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The mBCA 515 was compared to the gold standard methods MRI, DXA, ADP, D2O- and NaBr-dilution
      in previous clinical investigations (BCA-01, BCA-02, BCA-20) to generate prediction equations
      for calculating body composition (FFM, SMM, ECW, TBW and VAT) in different populations.
      Furthermore, normal ranges for body composition were generated based on the previous study
      BCA-03 conducted at the UKE.

      The mBCA 555 is a new body composition analyzer measuring bioimpedance in standing position
      developed by seca.

      In order to apply prediction equations and normal ranges from previous clinical
      investigations BCA-01, BCA-02, BCA-03 and BCA-20 to the new mBCA 555 it shall be compared to
      the mBCA 515.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BIA 5 and 50 kHz</measure>
    <time_frame>10 minutes</time_frame>
    <description>Bioelectrical Impedance of 5 and 50 kHz for one body side</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BIA 50 kHz</measure>
    <time_frame>10 minutes</time_frame>
    <description>Bioelectrical Impedance of 50 kHz for all 4 extremities</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete BIA</measure>
    <time_frame>10 minutes</time_frame>
    <description>Bioelectrical Impedance of 1, 1.5, 2, 3, 7.5, 10, 15, 20, 30, 75, 100, 150, 200, 300, 500, 750 and 1,000 kHz for all body segments: right arm, left arm, right leg, left leg, trunk, right body side and left body side.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Bioelectrical Impedance Measurement of Healthy Adults</condition>
  <eligibility>
    <study_pop>
      <textblock>
        healthy adults
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female subjects,

          -  18 years and older,

          -  subjects need to be able to sign the informed consent and privacy policy

        Exclusion Criteria:

          -  acute disease

          -  pregnancy

          -  intake of diuretics

          -  edema diagnosed by inspection and palpation of lower limbs

          -  paralysis e.g. after a stroke

          -  neurodegenerative diseases e.g. ALS

          -  tumors in treatment

          -  amputation

          -  electronic implants e.g. pacemaker

          -  probands who cannot provide an ICF by themselves

          -  probands who might be dependent from the sponsor or the investigation site

          -  current alcohol abuse

          -  active prostheses

          -  electronic life-support systems, e.g. artificial heart, artificial lung

          -  portable electronic medical devices, e.g. ECG devices or infusion pumps

          -  metallic implants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Sven Peine, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristin Klückmann</last_name>
    <phone>+4940200000</phone>
    <phone_ext>232</phone_ext>
    <email>Kristin.Klueckmann@seca.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Transfusion Medicine</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sven Peine, Dr.</last_name>
      <email>s.peine@uke.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 19, 2019</study_first_submitted>
  <study_first_submitted_qc>July 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2019</study_first_posted>
  <last_update_submitted>July 19, 2019</last_update_submitted>
  <last_update_submitted_qc>July 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>December 11, 2019</submitted>
    <returned>December 30, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

